Association between the modified Japanese Version of High Bleeding Risk scores and clinical outcomes in Japanese patients with lower extremity artery disease undergoing endovascular treatment
Heart Vessels. 2026 Jun;41(6):369-382.
doi: 10.1007/s00380-025-02629-0.
Epub 2025 Nov 23.
1 Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan. shimono.hirokazu@beige.plala.or.jp.
2 Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan.
3 Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
4 Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus School of Medicine, Okinawa, Japan.
Keywords:
Academic Research Consortium for High Bleeding Risk (ARC-HBR); Endovascular treatment (EVT); High bleeding risk; Lower extremity artery disease (LEAD); Modified Japanese Version of High Bleeding Risk (J-HBR).